Earnings Per Share (EPS): Change in analysts' estimates |
|
|
Turnover: Change in analysts' estimates |
|
| |
|
|
Abbvie raises sales outlook of two new drugs to more than $17.5 billion in 2025 |
Next year EPS consensus revisions
Revenue consensus revisions
Next year Revenue consensus revisions
|